Home
Non-Exec. & Independent Dir.
Non-Exec. & Independent Dir.
Company Sec. & Compli. Officer
Chairman & Managing Director
Whole-time Director
NSE: MARKSANS
Share Price
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
08 Jan 2025 | 283.4 | 293.25 | 295 | 281.15 |
07 Jan 2025 | 289.5 | 286.5 | 293 | 281.9 |
06 Jan 2025 | 285.35 | 300.55 | 300.55 | 282.55 |
03 Jan 2025 | 297.55 | 303.2 | 303.2 | 296.5 |
02 Jan 2025 | 298 | 304.85 | 307.1 | 296.95 |
01 Jan 2025 | 304.7 | 301.05 | 308.15 | 296.7 |
31 Dec 2024 | 296.7 | 285.7 | 298.15 | 285.7 |
30 Dec 2024 | 287.35 | 294 | 294.85 | 285.65 |
27 Dec 2024 | 293.6 | 290.2 | 296.55 | 290.2 |
26 Dec 2024 | 290.15 | 296.95 | 299.65 | 288.95 |
Date | Price (₹) |
---|---|
08 Jan 2025 | 283.4 |
07 Jan 2025 | 289.5 |
06 Jan 2025 | 285.35 |
03 Jan 2025 | 297.55 |
02 Jan 2025 | 298 |
01 Jan 2025 | 304.7 |
31 Dec 2024 | 296.7 |
30 Dec 2024 | 287.35 |
27 Dec 2024 | 293.6 |
26 Dec 2024 | 290.15 |
Market Cap
13,119 Cr
EPS
7.7
P/E Ratio (TTM)
37.8
P/B Ratio (TTM)
5.8
Day’s High
295.0
Day’s Low
281.15
DTE
0.1
ROE
15.2
52 Week High
358.5
52 Week Low
126.05
ROCE
19.0
1M
1Y
3Y
5Y
Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketing Authoriz
Read more
2024-08-21 00:00:00
The inspection has been classified as voluntary action indicated (VAI) and has been closed according
Read more
2024-08-20 00:00:00
Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR) for its
Read more
2024-08-20 00:00:00
Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be held on 24 Se
Read more
2024-08-20 00:00:00